Cargando…

Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity

Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborns with the birth dose (HepB-BD), second dose (HepB...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyuregyan, Karen K., Kichatova, Vera S., Isaeva, Olga V., Potemkin, Ilya A., Malinnikova, Elena Yu., Lopatukhina, Maria A., Karlsen, Anastasia A., Asadi Mobarhan, Fedor A., Mullin, Eugeniy V., Slukinova, Olga S., Ignateva, Margarita E., Sleptsova, Snezhana S., Oglezneva, Elena E., Shibrik, Elena V., Isaguliants, Maria G., Mikhailov, Mikhail I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912110/
https://www.ncbi.nlm.nih.gov/pubmed/33498794
http://dx.doi.org/10.3390/vaccines9020082
_version_ 1783656499941212160
author Kyuregyan, Karen K.
Kichatova, Vera S.
Isaeva, Olga V.
Potemkin, Ilya A.
Malinnikova, Elena Yu.
Lopatukhina, Maria A.
Karlsen, Anastasia A.
Asadi Mobarhan, Fedor A.
Mullin, Eugeniy V.
Slukinova, Olga S.
Ignateva, Margarita E.
Sleptsova, Snezhana S.
Oglezneva, Elena E.
Shibrik, Elena V.
Isaguliants, Maria G.
Mikhailov, Mikhail I.
author_facet Kyuregyan, Karen K.
Kichatova, Vera S.
Isaeva, Olga V.
Potemkin, Ilya A.
Malinnikova, Elena Yu.
Lopatukhina, Maria A.
Karlsen, Anastasia A.
Asadi Mobarhan, Fedor A.
Mullin, Eugeniy V.
Slukinova, Olga S.
Ignateva, Margarita E.
Sleptsova, Snezhana S.
Oglezneva, Elena E.
Shibrik, Elena V.
Isaguliants, Maria G.
Mikhailov, Mikhail I.
author_sort Kyuregyan, Karen K.
collection PubMed
description Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborns with the birth dose (HepB-BD), second dose (HepB-2nd), and three vaccine doses (HepB3) in two remote regions of Russia with low (Belgorod Oblast) and high (Yakutia) levels of hepatitis B virus (HBV) endemicity. Vaccination data were obtained from the medical records of 1000 children in Yakutia and 2182 children in Belgorod Oblast. Sera of healthy volunteers from Belgorod Oblast (n = 1754) and Yakutia (n = 1072) across all age groups were tested for serological markers of HBV to assess the infection prevalence and herd immunity. Average HepB-BD coverage was 99.2% in Yakutia and 89.4% in Belgorod Oblast (p < 0.0001) and in both regions varied significantly, from 66% to 100%, between medical centers. The principal reason for the absence of HepB-BD was parent refusal, which accounted for 63.5% of cases of non-vaccination (83/123). While timely HepB-2nd coverage was only 55.4%–64.7%: HepB3 coverage by the age of one year exceeded 90% in both study regions. HBV surface antigen (HBsAg) prevalence in the 1998–2019 birth cohort was 0.2% (95% CI: 0.01–1.3%) in Belgorod Oblast and 3.2% (95% CI: 1.9–5.2%) in Yakutia. The proportion of persons testing negative for both antibodies to HBsAg (anti-HBs) and antibodies to HBV core antigen (anti-HBc) in the 1998–2019 birth cohort was 26.2% (125/481) in Belgorod Oblast and 32.3% (162/501) in Yakutia. We also assessed the knowledge of and attitude towards vaccination among 782 students and teachers of both medical and non-medical specialties from Belgorod State University. Only 60% of medical students knew that hepatitis B is a vaccine-preventable disease. Both medical and nonmedical students, 37.8% and 31.3%, respectively, expressed concerns about safety and actual necessity of vaccination. These data indicate the need to introduce a vaccine delivery audit system, improve medical education with respect to vaccination strategies and policies, and reinforce public knowledge on the benefits of vaccination.
format Online
Article
Text
id pubmed-7912110
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79121102021-02-28 Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity Kyuregyan, Karen K. Kichatova, Vera S. Isaeva, Olga V. Potemkin, Ilya A. Malinnikova, Elena Yu. Lopatukhina, Maria A. Karlsen, Anastasia A. Asadi Mobarhan, Fedor A. Mullin, Eugeniy V. Slukinova, Olga S. Ignateva, Margarita E. Sleptsova, Snezhana S. Oglezneva, Elena E. Shibrik, Elena V. Isaguliants, Maria G. Mikhailov, Mikhail I. Vaccines (Basel) Article Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborns with the birth dose (HepB-BD), second dose (HepB-2nd), and three vaccine doses (HepB3) in two remote regions of Russia with low (Belgorod Oblast) and high (Yakutia) levels of hepatitis B virus (HBV) endemicity. Vaccination data were obtained from the medical records of 1000 children in Yakutia and 2182 children in Belgorod Oblast. Sera of healthy volunteers from Belgorod Oblast (n = 1754) and Yakutia (n = 1072) across all age groups were tested for serological markers of HBV to assess the infection prevalence and herd immunity. Average HepB-BD coverage was 99.2% in Yakutia and 89.4% in Belgorod Oblast (p < 0.0001) and in both regions varied significantly, from 66% to 100%, between medical centers. The principal reason for the absence of HepB-BD was parent refusal, which accounted for 63.5% of cases of non-vaccination (83/123). While timely HepB-2nd coverage was only 55.4%–64.7%: HepB3 coverage by the age of one year exceeded 90% in both study regions. HBV surface antigen (HBsAg) prevalence in the 1998–2019 birth cohort was 0.2% (95% CI: 0.01–1.3%) in Belgorod Oblast and 3.2% (95% CI: 1.9–5.2%) in Yakutia. The proportion of persons testing negative for both antibodies to HBsAg (anti-HBs) and antibodies to HBV core antigen (anti-HBc) in the 1998–2019 birth cohort was 26.2% (125/481) in Belgorod Oblast and 32.3% (162/501) in Yakutia. We also assessed the knowledge of and attitude towards vaccination among 782 students and teachers of both medical and non-medical specialties from Belgorod State University. Only 60% of medical students knew that hepatitis B is a vaccine-preventable disease. Both medical and nonmedical students, 37.8% and 31.3%, respectively, expressed concerns about safety and actual necessity of vaccination. These data indicate the need to introduce a vaccine delivery audit system, improve medical education with respect to vaccination strategies and policies, and reinforce public knowledge on the benefits of vaccination. MDPI 2021-01-23 /pmc/articles/PMC7912110/ /pubmed/33498794 http://dx.doi.org/10.3390/vaccines9020082 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kyuregyan, Karen K.
Kichatova, Vera S.
Isaeva, Olga V.
Potemkin, Ilya A.
Malinnikova, Elena Yu.
Lopatukhina, Maria A.
Karlsen, Anastasia A.
Asadi Mobarhan, Fedor A.
Mullin, Eugeniy V.
Slukinova, Olga S.
Ignateva, Margarita E.
Sleptsova, Snezhana S.
Oglezneva, Elena E.
Shibrik, Elena V.
Isaguliants, Maria G.
Mikhailov, Mikhail I.
Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title_full Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title_fullStr Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title_full_unstemmed Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title_short Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity
title_sort coverage with timely administered vaccination against hepatitis b virus and its influence on the prevalence of hbv infection in the regions of different endemicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912110/
https://www.ncbi.nlm.nih.gov/pubmed/33498794
http://dx.doi.org/10.3390/vaccines9020082
work_keys_str_mv AT kyuregyankarenk coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT kichatovaveras coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT isaevaolgav coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT potemkinilyaa coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT malinnikovaelenayu coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT lopatukhinamariaa coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT karlsenanastasiaa coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT asadimobarhanfedora coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT mullineugeniyv coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT slukinovaolgas coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT ignatevamargaritae coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT sleptsovasnezhanas coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT ogleznevaelenae coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT shibrikelenav coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT isaguliantsmariag coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity
AT mikhailovmikhaili coveragewithtimelyadministeredvaccinationagainsthepatitisbvirusanditsinfluenceontheprevalenceofhbvinfectionintheregionsofdifferentendemicity